drugset / Trial / NCT03985865

IG vs ID Bitter Administration

NCT03985865

Phase 4 Completed 14 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverSingle-blindBasic science

Summary

We want to investigate whether bitter compounds, denatonium benzoate and quinine hydrochloride, have a distinct effect on gastrointestinal hormone release after infusion into the stomach or duodenum. Furthermore, we want to observe an effect on hunger sensations and hedonic food intake. Moreover, we suggest somatostatin as a driving factor for decreased motilin and ghrelin release after intragastric administration.

Timeline

Start
2017-03-02
Primary completion
2018-05-07
Completion
2018-05-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinine Small molecule 10 unknown Other
Subject denatonium benzoate Unknown 1 unknown Other

Indications